ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 30.49
+1.17 (3.99%)
At close: Sep 30, 2026
ChengDa Pharmaceuticals Market Cap
ChengDa Pharmaceuticals has a market cap or net worth of 4.62 billion as of October 2, 2026. Its market cap has decreased by -0.72% in one year.
Market Cap
4.62B
Enterprise Value
3.69B
Revenue
479.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.49
ChartMarket Cap Chart
Since January 20, 2022, ChengDa Pharmaceuticals's market cap has decreased from 12.43B to 4.62B, a decrease of -62.85%. That is a compound annual growth rate of -19.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.62B | -25.09% |
| Dec 31, 2025 | 6.16B | 101.68% |
| Dec 31, 2024 | 3.06B | -22.31% |
| Dec 29, 2023 | 3.93B | -19.91% |
| Dec 30, 2022 | 4.91B | -60.48% |
| Jan 20, 2022 | 12.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding